Key facts
- This page summarizes Boxer Capital, LLC's Form 4 filing for Rain Oncology Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 24 May 2023, 20:05.
Boxer Capital, LLC - 22 May 2023 Form 4 Insider Report for Rain Oncology Inc.
- Reporting relationship
- Aaron Davis, the CEO of Boxer Capital, LLC, is a director of Rain Oncology Inc.
- Issuer ticker
- N/A
- Reported as of
- 22 May 2023
- Net transaction value
- -$1,243,750
- SEC form
- 4
- Accepted by SEC
- 24 May 2023, 20:05:53 UTC
- Prior SEC filing
- 13 Oct 2022
- Next SEC filing
- 15 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Aaron I. Davis, Chief Executive Officer, Boxer Capital, LLC
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Boxer Capital, LLC filed Form 4 for Rain Oncology Inc. on 24 May 2023.
Change
- Previous filing in this sequence was filed on 13 Oct 2022.
- Current net transaction value: -$1,243,750.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RAIN
transaction
Common Stock
Sale
- Transaction value
- $1,243,750
- Shares
- -995,000
- Change %
- -46%
- Price
- $1.25
- Shares after
- 1,152,212
- Date
- 22 May 2023
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.30, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Footnote F2
These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) Aaron I. Davis, (iv) MVA Investors, LLC, and (v) Joe Lewis (collectively, the "Boxer Group"). Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein
Footnote F3
These securities are owned indirectly by Boxer Management and Joe Lewis, by virtue of their ownership of Boxer Capital.
SEC remarks
Aaron Davis, the CEO of Boxer Capital, LLC, is a director of Rain Oncology Inc.